Blood-Borne Diseases

The first study to evaluate the cost-effectiveness of hepatitis C virus (HCV) screening among pregnant women in the US in the era of direct-acting antiviral (DAA) treatment demonstrates that it would be "highly" cost effective, even in states with low HCV prevalence.

Violence in the Democratic Republic of Congo has complicated public health efforts and overshadowed strides made in the response to the Ebola outbreak there.

UK study in Addiction identifies benefits for controversial programs proposed as a solution for the ongoing opioid crisis.

A new study reports that many health care workers had the ability to neutralize the Ebola virus, despite never exhibiting symptoms of infection.

Investigators have detected the presence of Ebola in a bat in Liberia, revealing more about how bats serve as reservoirs for the deadly pathogen.

A new analysis sheds light on what is needed to hit this benchmark.

Women living in or traveling to Africa and the Middle East should take precautions and avoid contact with mosquitoes and livestock.

Melvin Weinstein MD, discusses the emerging technologies that will advance the field of blood culture testing.

Kenneth Sherman, MD, discusses hepatitis B infections in immunocompromised patients and what clinicians should expect to see in the future for hepatitis B treatment.

Even when men who have sex with men are aware of the risk of hepatitis C infection, they aren’t always confident in their ability to go against the expectations of their peer group.

A new report shows improvement in some areas but a vast gap in US health care readiness still exists.

What’s happening in the African nation is only the latest example of the catch-22 caused by political unrest and infectious disease outbreaks.

Investigators have identified Marburg virus in Sierra Leone bats, marking the first time the hemorrhagic fever has been discovered in West Africa.

Patients with the hepatitis C virus who are on Medicaid in Oregon can expect to receive curative treatment in 2019, without having to wait for liver damage to set in.

We've compiled a list of the top 9 infectious disease outbreaks of 2019.

Successful treatment of recently acquired hepatitis C virus infection in 8 weeks, with a regimen currently approved for 12 weeks, could enable shorter, less costly treatment.

New findings on the ways Ebola proteins connect with human proteins may lead to a novel treatment for Ebola virus infections.

A lack of funding is currently hindering response where it’s needed most; the supply of clean water and sanitation.

Through retrospective analysis, investigators have identified a second case of rat hepatitis E virus in a human, which has close genetic relation to the first case.

A new trial evaluating the efficacy of investigational therapeutics mAb114, remdesivir, and ZMapp has launched in the Democratic Republic of the Congo.

People who inject drugs who are infected with hepatitis C virus can achieve sustained viral response, despite imperfect adherence, according to the results of a new trial.

Sixteen WHO health workers have been evacuated from the epicenter of the outbreak following an attack on their residence.

A new approach to hepatitis C virus infection treatment could shave time and costs off the current standard regimen.

The current Ebola outbreak in the Democratic Republic of Congo has surpassed 300 cases and international health officials are now questioning if it is capable of being controlled.

Building on decades-old research, scientists in France say they’ve developed an effective rectal delivery formulation of an antibiotic used to save infants with life-threatening neonatal sepsis.